GTC presented abstracts at ASH 2024 GTC’s posters from 2024 Convention of American Society of Hematology are now available to be downloaded. Please reach out
Just published in The Journal of Liquid Biopsy Liquid biopsy for evaluating mutations and chromosomal aberrations in cerebrospinal fluid from patients with primary or metastatic
Lake Forest, CA – November 13, 2024 – Genomic Testing Cooperative (GTC), a leader in advanced genomic testing, announced the launch of GTC Interpret, a
Maher Albitar, Ahmad Charifa, Sally Agersborg, Andrew Pecora, Andrew Ip, Andre Goy Abstract: Most of the current utilization of liquid biopsy (LBx) is based on
Manchester, NH – June 25, 2024 – BioAI, an emerging biotech company applying multimodal artificial intelligence (AI) to novel biomarker discovery, development, and diagnostics, announced a strategic collaboration with Genomic Testing Cooperative (GTC), a leading provider of molecular diagnostics for solid tumors and hematologic malignancies. This collaboration leverages the AI capabilities of both companies to deliver innovative solutions that meet the needs of pharmaceutical companies and clinicians, ultimately enhancing patient care in oncology. GTC will become an early technology access member of BioAI’s global ecosystem of clinical laboratories.
GTC is excited to be exhibiting at the American Society of Hematology (ASH) conference in San Diego on December 6-9, 2024. You can find us
Innovation Spotlight Information Stage Number: Innovation Spotlight Stage #1 Innovation Spotlight Date: Thursday, November 21, 2024 Innovation Spotlight Time: 4:25 PM – 4:55 PMInnovation Spotlight Title: The Role of
Join Genomic Testing Cooperative at the Advancing Precision Medicine Annual Conference and Expo 2024 in Philadelphia, PA on November 1-2. As pioneers in genomics, we’re